Fatty acid metabolism disorders and potential therapeutic traditional Chinese medicines in cardiovascular diseases

Phytother Res. 2023 Nov;37(11):4976-4998. doi: 10.1002/ptr.7965. Epub 2023 Aug 2.

Abstract

Cardiovascular diseases are currently the primary cause of mortality in the whole world. Growing evidence indicated that the disturbances in cardiac fatty acid metabolism are crucial contributors in the development of cardiovascular diseases. The abnormal cardiac fatty acid metabolism usually leads to energy deficit, oxidative stress, excessive apoptosis, and inflammation. Targeting fatty acid metabolism has been regarded as a novel approach to the treatment of cardiovascular diseases. However, there are currently no specific drugs that regulate fatty acid metabolism to treat cardiovascular diseases. Many traditional Chinese medicines have been widely used to treat cardiovascular diseases in clinics. And modern studies have shown that they exert a cardioprotective effect by regulating the expression of key proteins involved in fatty acid metabolism, such as peroxisome proliferator-activated receptor α and carnitine palmitoyl transferase 1. Hence, we systematically reviewed the relationship between fatty acid metabolism disorders and four types of cardiovascular diseases including heart failure, coronary artery disease, cardiac hypertrophy, and diabetic cardiomyopathy. In addition, 18 extracts and eight monomer components from traditional Chinese medicines showed cardioprotective effects by restoring cardiac fatty acid metabolism. This work aims to provide a reference for the finding of novel cardioprotective agents targeting fatty acid metabolism.

Keywords: cardiovascular disease; fatty acid metabolism; traditional Chinese medicine.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Cardiovascular Diseases* / drug therapy
  • Energy Metabolism
  • Fatty Acids
  • Heart
  • Humans
  • Medicine, Chinese Traditional
  • PPAR alpha / metabolism

Substances

  • PPAR alpha
  • Fatty Acids